Today, our screeners were at work and below is a list of 4 HealthTech Stocks up over 73% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
Summary: InflaRx N.V. is a clinical-stage biopharmaceutical company. It focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. InflaRx N.V. is based in Germany.
Recent IFRX Stock Price (approx 10:00am EST.): $2.99
Previous Close for IFRX Stock: $2.79
Percentage Price Change Past 10 Days for IFRX stock: +92%
What is the forecast for IFRX stock? Here are 3rd party ratings for IFRX stock:
|
What’s the sentiment on the street for IFRX stock? Current ratings compiled by TipRanks.com)
|
Click for the IFRX stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Ayala Pharmaceuticals Inc. is a clinical-stage oncology company. It focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. Ayala Pharmaceuticals Inc. is based in Rehovot, Israel.
Recent AYLA Stock Price (approx 10:00am EST.): $1.65
Previous Close for AYLA Stock: $1.63
Percentage Price Change Past 10 Days for AYLA stock: +84%
What is the forecast for AYLA stock? Here are 3rd party ratings for AYLA stock:
|
What’s the sentiment on the street for AYLA stock? Current ratings compiled by TipRanks.com)
|
Click for the AYLA stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Aridis Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the discovery and development of immunotherapy using fully human monoclonal antibodies to treat life-threatening infections. The company's product pipeline consists of AR-301, AR-105, AR-101, AR-401, AR-201 and AR-501 which are in clinical stages. Aridis Pharmaceuticals, Inc. is based in San Jose, United States.
Recent ARDS Stock Price (approx 10:00am EST.): $2.05
Previous Close for ARDS Stock: $2.03
Percentage Price Change Past 10 Days for ARDS stock: +75%
What is the forecast for ARDS stock? Here are 3rd party ratings for ARDS stock:
|
What’s the sentiment on the street for ARDS stock? Current ratings compiled by TipRanks.com)
|
Click for the ARDS stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: CytoDyn is a biotechnology company focused on the clinical development and potential commercialization of humanized monoclonal antibodies for the treatment and prevention of HIV infection. The Company has one of the leading monoclonal antibodies under development for HIV infection, PRO 140, which has completed Phase 2 clinical trials with demonstrated antiviral activity in humans and is currently in Phase 3 development. PRO 140 blocks the HIV co-receptor CCR5 on T cells, which prevents viral entry.
Recent CYDY Stock Price (approx 10:00am EST.): $1.04
Previous Close for CYDY Stock: $1.01
Percentage Price Change Past 10 Days for CYDY stock: +73%
What is the forecast for CYDY stock? Here are 3rd party ratings for CYDY stock:
|
What’s the sentiment on the street for CYDY stock? Current ratings compiled by TipRanks.com)
|
Click for the CYDY stock Chart >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.